By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Phone: Fax:


Company News
Positive Results Of Phase IIb Clinical Trial Of Pharmalink AB's Nefecon In Primary IgA Nephropathy Published In The Lancet 3/29/2017 7:37:37 AM
International Myeloma Foundation Release: Landmark Study Published Today In The Lancet Shows Clear Myeloma Survival Benefit With Triple Drug Combination 12/27/2016 6:27:39 AM
Galapagos (GLPG.BR) Release: The Lancet Publishes FITZROY Study Results With Filgotinib In Crohn's 12/15/2016 10:21:25 AM
Amgen (AMGN) And Cytokinetics (CYTK) Release: The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved Cardiac Function In Patients With Chronic Heart Failure 12/1/2016 7:10:42 AM
UCB, Inc. (UCBJF.PK) Release: The Lancet Publishes First Head-To-Head Study Of CIMZIA (Certolizumab Pegol) And Humira (Adalimumab) In Bio-Naïve Rheumatoid Arthritis Patients 11/15/2016 10:22:38 AM
Interleukin Genetics (ILGN) Cites Role in Key Antisense Drug Trial Published In The Lancet 9/22/2016 8:49:28 AM
Akcea Therapeutics Announces Publication in The Lancet Of Clinical Results With Lp(a)-Lowering Drugs Designed To Treat Cardiovascular Disease 9/22/2016 7:24:59 AM
Takeda (TKPYY) And TiGenix Announce Publication In The Lancet Of 24-Week Results Of The Phase 3 ADMIRE-CD Trial Investigating Cx601 In The Treatment Of Complex Perianal Fistulas In Patients With Crohn's Disease 8/2/2016 6:42:44 AM
Data In The Lancet Show Olaratumab Plus Doxorubicin Offered 11.8-Month Increase In Overall Survival In Patients With Advanced Soft Tissue Sarcoma, As Reported By Eli Lilly (LLY) And Memorial Sloan-Kettering Cancer Center Researchers 6/10/2016 10:17:10 AM
Children’s Hospital Colorado Release: Research Behind Global Switch To New Polio Vaccine Strategy Released In The Lancet 5/24/2016 8:31:27 AM